Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 993 results for "novartis"

Novartis Links With BiolineRX To Develop Israel-Made Drugs

By Estel Grace Masangkay Israeli clinical-stage biopharmaceutical company BioLineRX announced that it has signed up Swiss pharma giant Novartis in a multi-year strategic collaboration to develop and commercialize Israeli-sourced drug candidates. ...
 Bioresearch Online1 hour ago BioLineRx, Novartis to develop and commercialize Israeli-sourced drug candidates  Pharmaceutical Business Review1 week ago
Money Control

Mylan Launches Generic Version of Menopause Drug

Acquisition of the Habitrol Brand From Novartis We are happy to announce that we have received consent from the U.S. Federal Trade Commission for our acquisition of the Habitrol® brand, an over-the-counter nicotine replacement therapy transdermal ...
 Pharmacy Times19 hours ago Acquisition of the Habitrol Brand From Novartis  Pharmacy Times2 days ago DR REDDY LABORATORIES : Drl closes acquisition of novartis' habitrol  4 Traders2 days ago Dr Reddy's Laboratories Acquires Habitrol Brand From Novartis  4 Traders2 days ago
[x]  
NDTV Profit

Novartis shares up nearly 2% at close

MUMBAI: Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 per cent higher today, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants ...
 Economic Times1 day ago Naidu welcomes Bharat Ratna for Vajpayee, Malaviya  Business Standard India1 day ago Novartis clarifies on CCI approval for GSK Pharma Deal  India Infoline1 day ago CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis  Financial Express2 days ago
[x]  

Novartis announces favorable results from acute lymphoblastic leukemia study

Novartis AG has announced results from a long-term study in pediatric patients with acute lymphoblastic leukemia, or ALL, which showed that 36 of 39 pediatric patients with relapsed/refractory, or r/r, ALL, or 92%, experienced complete remissions, ...
 Individual.com1 day ago
Forbes.com

Interesting NVS Put And Call Options For February 2015

Investors in Novartis (NYSE: NVS) saw new options become available this week, for the February 2015 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVS options chain for the new February 2015 contracts and ...
 Austin American Statesman1 day ago
Bidness Etc

Lilly must divest Sentinel products after FTC nod on Novartis deal

(Adds details on divestiture, background on deal, share price) By Diane Bartz WASHINGTON, Dec 22 (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG's animal health unit on condition that it divests its Sentinel line of products ...
 Yahoo! Finance3 days ago FTC Puts Conditions on Eli Lilly's Proposed Acquisition of Novartis Animal Health  Federal Trade Commission3 days ago Lilly to divest some Sentinel products to win approval on Novartis  Reuters UK3 days ago Eli Lilly Must Sell Dog Heartworm Line to Buy Novartis AG's Animal Health Unit  BioSpace2 days ago
[x]  

Vanda settles Fanapt license arbitration proceedings with Novartis

Vanda Pharmaceuticals Inc. has reached a settlement agreement with Novartis AG (Novartis) related to the ongoing Fanapt license arbitration proceedings. The parties have agreed to dismiss the ongoing Fanapt arbitration and to release each other from ...
 PharmaBiz2 days ago Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog  Zacks.com1 day ago Vanda Settle Fanapt Arbitration With Novartis  RTTNews.com3 days ago Vanda Pharmaceuticals (VNDA) Reaches Settlement with Novartis AG  InvestorGuide.com2 days ago
[x]  

MorphoSys receives clinical milestone from Novartis in oncology programme

MorphoSys AG has received a milestone payment from Novartis in connection with the initiation of a phase 1 clinical trial of a HuCAL antibody in the field of oncology. This becomes the tenth therapeutic antibody made using MorphoSys's technologies ...
 PharmaBiz3 days ago Morphosys gets payment from Novartis for oncology research  Reuters UK4 days ago MorphoSys AG Receives Milestone Payment From Novartis  Swissquote4 days ago
Livemint.com

CCI approves Novartis-Glaxo merger of certain business portfolios

GSK will acquire Novartis's global human vaccine business, excluding its influenza vaccine business. Photo: Bloomberg New Delhi: The Competition Commission of India (CCI) has approved the merging of certain business portfolios of Swiss drug maker ...
 Livemint.com2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less